Laparoscopy Systems in Massachusetts

Medical Component Specialists, Inc. (MCS) is a certified Veteran-Owned Business and ISO 13485/FDA-registered contract manufacturer specializing in precision medical components for OEM suppliers. Founded in 2002 and based in Bellingham, Massachusetts, MCS operates three manufacturing facilities totaling 68,000+ square feet, including an 18,000-sq-ft nitrinol CNC machining facility and a 50,000-sq-ft input tube facility. The company manufactures high-precision components including cannulated drills, nitinol wires, orthopedic pins, mandrels, and specialty instruments for orthopedics, minimally invasive surgery, and interventional therapies. MCS combines over 60 years of family grinding craftsmanship with modern lean manufacturing, offering full in-line services including process design, rapid prototyping, precision production, and flexible finishing/assembly with lot traceability. The QuickShip Protolab enables rapid custom manufacturing.

KARL STORZ is a global medical technology manufacturer specializing in endoscopic visualization systems, minimally invasive surgical instruments, and operating room integration solutions. The company develops and manufactures rigid and flexible endoscopes, laparoscopic and arthroscopic equipment, video laryngoscopes for airway management, and specialized instruments for general and visceral surgery, urology, otorhinolaryngology, gynecology, and gastroenterology. KARL STORZ offers comprehensive imaging solutions including camera systems, light sources, and monitors designed for integration into surgical workflows. The product portfolio exceeds 15,000 items spanning telescopes, instruments, electrosurgical devices, and OR integration systems. The company serves hospitals, surgical centers, and specialized practices globally. KARL STORZ provides extensive customer support including product manuals, online catalogs, repair and maintenance services, and training programs through dedicated training centers. The company has pioneered video laryngoscope technology and maintains leadership in endoscopic visualization and laparoscopic surgery solutions. All products are manufactured to medical device standards including FDA clearance and international regulatory compliance. The organization partners with leading physicians, universities, and research institutes to identify clinical trends and translate them into innovative surgical solutions.

Activ Surgical is a Boston-based digital surgery company specializing in hardware-agnostic surgical software and intraoperative imaging technologies designed to enhance visualization and reduce surgical errors. The company's flagship product, ActivSight™ Intelligent Light, is FDA-cleared and integrates with existing laparoscopic and robotic surgical systems to provide real-time visualization of blood flow and tissue perfusion. ActivSight offers surgeons critical physiological insights invisible to the naked eye through dye-free ActivPerfusion™ and ActivICG™ imaging modes. The patent-protected ActiveEdge™ platform leverages augmented reality, artificial intelligence, and machine learning to improve intraoperative decision-making and address preventable surgical complications. Activ Surgical has achieved significant milestones including the world's first autonomous robotic surgery of soft tissue and CE Mark approval. With $87.5 million in funding, the company operates pilot sites in major U.S. hospital networks, addressing the critical clinical need that preventable surgical errors contribute to over 400,000 deaths annually in the U.S.

Microline Surgical manufactures reposable surgical instruments designed to reduce total cost of ownership and environmental impact while maintaining surgical precision and safety. The company specializes in laparoscopic and electrosurgical instrument platforms that enable healthcare facilities to balance quality instrument performance with cost efficiency. Their reposable instrument approach replaces traditional single-use disposables, allowing surgeons access to precision instruments with new tips while reducing waste and facility expenses. The company serves operating rooms and surgical centers, with particular emphasis on minimally invasive procedures. Microline's solutions are positioned for healthcare professionals seeking sustainable, cost-effective surgical instrument management without compromising clinical outcomes. The company has demonstrated market expansion through strategic acquisitions, including surgical instrumentation assets from Retraction Limited (2023), indicating growth in their surgical instrument portfolio.

Freyja Healthcare develops surgical devices focused on minimally invasive procedures, with initial concentration on women's health. The company's flagship product, VereSee™, is the first 2mm laparoscopic entry device with integrated high-definition video for direct visualization during abdominal access. VereSee™ eliminates blind entry during laparoscopic procedures, enabling surgeons to visualize the insertion site in real time, thereby improving surgical accuracy and efficiency. The device received FDA 510(k) clearance in May 2024. Freyja Healthcare is positioned to expand beyond women's health into broader surgical applications. The company emphasizes precision, innovation, and control in surgical tool design, addressing gaps in a market segment historically characterized by limited innovation.

ATC Technologies Inc is an ISO 13485 certified medical device manufacturer based in Wilmington, Massachusetts, specializing in contract manufacturing and design of surgical instruments and diagnostic devices since 1989. The company develops electrocautery instruments, biopsy forceps, laparoscopy tools, pencil electrodes, and handheld electrode probes for surgical and cardiology applications. ATC provides end-to-end services from clinical need definition through design, FDA-regulated testing, approval, manufacturing, and distribution, with a focus on quality assurance, enhanced performance, and patient care outcomes. The company serves as an OEM manufacturer and partner for medical device innovation.